Abstract
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 27- or 38-amino acid neuropeptide, which belongs to the vasoactive intestinal polypeptide/glucagon/secretin family. PACAP and its three receptor subtypes are expressed in neural tissues of the eye, including the retina, cornea and lacrimal gland, and PACAP is known to exert pleiotropic effects throughout the central nervous system. This review provides an overview of current knowledge regarding the cell protective effects, mechanisms of action and therapeutic potential of PACAP in response to several types of eye injury.
Keywords:
Dry eye; Neurotropic function; PACAP; Retinoprotection.
MeSH terms
-
Animals
-
Cornea / metabolism
-
Eye Diseases / drug therapy
-
Humans
-
Lacrimal Apparatus / metabolism
-
Mice
-
Nerve Tissue / metabolism
-
Neuroprotective Agents*
-
Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism
-
Pituitary Adenylate Cyclase-Activating Polypeptide / pharmacology*
-
Pituitary Adenylate Cyclase-Activating Polypeptide / physiology*
-
Pituitary Adenylate Cyclase-Activating Polypeptide / therapeutic use
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism
-
Retina / metabolism
Substances
-
Neuroprotective Agents
-
Pituitary Adenylate Cyclase-Activating Polypeptide
-
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide